» Articles » PMID: 35723354

Therapeutic Anti-Depressant Potential of Microbial GABA Produced by Strains for GABAergic Signaling Restoration and Inhibition of Addiction-Induced HPA Axis Hyperactivity

Overview
Publisher MDPI
Specialty Molecular Biology
Date 2022 Jun 20
PMID 35723354
Authors
Affiliations
Soon will be listed here.
Abstract

The role of the microbiota-gut-brain (MGB) axis in mood regulation and depression treatment has gained attention in recent years, as evidenced by the growing number of animal and human studies that have reported the anti-depressive and associated gamma-aminobutyric acid-ergic (GABAergic) effects of probiotics developed from bacterial strains in the gut microbiome. The depressive states attenuated by these probiotics in patients suffering from clinical depression also characterize the severe and relapse-inducing withdrawal phase of the addiction cycle, which has been found to arise from the intoxication-enabled hyperregulation of the hypothalamic-pituitary-adrenal (HPA) axis, the body's major stress response system, and a corresponding attenuation of its main inhibitory system, the gamma-aminobutyric acid (GABA) signaling system. Therefore, the use of probiotics in the treatment of general cases of depression provides hope for a novel therapeutic approach to withdrawal depression remediation. This review discusses potential therapeutic avenues by which probiotic application of strains can be used to restore the central GABAergic activity responsible for attenuating the depression-inducing HPA axis hyperactivity in addiction withdrawal. Also, information is provided on brain GABAergic signaling from other known GABA-producing strains of gut microbiota.

Citing Articles

Promising Antidepressant Potential: The Role of Lactobacillus rhamnosus GG in Mental Health and Stress Response.

Isik M, Kose F, Ozbayer C, Budak O, Kaya R, Erdogan D Probiotics Antimicrob Proteins. 2025; .

PMID: 39962033 DOI: 10.1007/s12602-025-10470-0.


Protective Effects of Bifidobacterium Breve MCC1274 as a Novel Therapy for Alzheimer's Disease.

Abdelhamid M, Counts S, Zhou C, Hida H, Kim J, Michikawa M Nutrients. 2025; 17(3).

PMID: 39940416 PMC: 11820889. DOI: 10.3390/nu17030558.


Water pollution, cholera, and the role of probiotics: a comprehensive review in relation to public health in Bangladesh.

Chowdhury M, Islam A, Yurina V, Shimosato T Front Microbiol. 2025; 15:1523397.

PMID: 39877756 PMC: 11772269. DOI: 10.3389/fmicb.2024.1523397.


The Role of Nutrition, Oxidative Stress, and Trace Elements in the Pathophysiology of Autism Spectrum Disorders.

Dlugosz A, Wroblewski M, Blaszak B, Szulc J Int J Mol Sci. 2025; 26(2).

PMID: 39859522 PMC: 11765825. DOI: 10.3390/ijms26020808.


Gut microbiome and metabolome library construction based on age group using short-read and long-read sequencing techniques in Korean traditional canine species Sapsaree.

Son S, Kang M, Kang A, Kang Y, Kim K, Kwak M Front Microbiol. 2024; 15:1486566.

PMID: 39712896 PMC: 11659757. DOI: 10.3389/fmicb.2024.1486566.


References
1.
Bravo J, Forsythe P, Chew M, Escaravage E, Savignac H, Dinan T . Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc Natl Acad Sci U S A. 2011; 108(38):16050-5. PMC: 3179073. DOI: 10.1073/pnas.1102999108. View

2.
Bonaz B, Sinniger V, Pellissier S . The Vagus Nerve in the Neuro-Immune Axis: Implications in the Pathology of the Gastrointestinal Tract. Front Immunol. 2017; 8:1452. PMC: 5673632. DOI: 10.3389/fimmu.2017.01452. View

3.
Ricci A, Allende A, Bolton D, Chemaly M, Davies R, Girones R . Update of the list of QPS-recommended biological agents intentionally added to food or feed as notified to EFSA 5: suitability of taxonomic units notified to EFSA until September 2016. EFSA J. 2020; 15(3):e04663. PMC: 7328882. DOI: 10.2903/j.efsa.2017.4663. View

4.
Plaza-Diaz J, Ruiz-Ojeda F, Gil-Campos M, Gil A . Immune-Mediated Mechanisms of Action of Probiotics and Synbiotics in Treating Pediatric Intestinal Diseases. Nutrients. 2018; 10(1). PMC: 5793270. DOI: 10.3390/nu10010042. View

5.
Appel-da-Silva M, Narvaez G, Perez L, Drehmer L, Lewgoy J . Saccharomyces cerevisiae var. boulardii fungemia following probiotic treatment. Med Mycol Case Rep. 2017; 18:15-17. PMC: 5537395. DOI: 10.1016/j.mmcr.2017.07.007. View